Table 1 Financing entities | 2009 Global/Spanish | 2010 Global/Spanish | 2011 Global/Spanish |
Government | 58(53.7%)/41(50%) | 52(52%)/20(58.8%) | 25(29.4%)/17(40.4%) |
Insurance | 3(2.7%)/-- | --/-- | --/-- |
Scientific Societies | 6(5.5%)/8(9.7%) | 7(7%)/5(14.7%) | 1(1.2%)/3(7.1%) |
Pharmaceutical Laboratories | 8(7.4%)/2(2.4%) | 8(8%)/3(8.8%) | 37(43.5%)/15(35.7%) |
Foundations-Private Institutes | 18(16.6%)/16(19.5%) | 19(19%)/3(8.8%) | 10(11.7%)/4(9.5%) |
Universities | 14(12.9%)/10/12.1%) | 9(9%)/2(5.8%) | 3(3.5%)/3(7.1%) |
Non-pharmaceutical companies | 2(1.9%)/5(6.1%) | 3(3%)/1(2.9%) | 6(7%)/-- |
Hospitals | 1(0.9%)/-- | 2(2%)/-- | 3(3.5%/-- |